PTRH2 and ductal breast carcinoma in situ: Quantification of the average Bit1 staining (Figure 1B) confirmed the similar Bit1 expression between the normal and DCIS subgroups and the reduction of Bit1 immunoreactivity in invasive nodal negative and positive breast carcinoma tissues as compared to normal/DCIS subgroups.